Literature DB >> 6259535

3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain.

D R Hill, N G Bowery.   

Abstract

The presence of a novel receptor for the neurotransmitter gamma-aminobutyric acid (GABA) on peripheral autonomic nerve terminals and in mammalian brain slices has been described recently. This receptor differs from the classical GABA site as it is unaffected by recognized GABA antagonists such as bicuculline and is not sensitive to the majority of accepted GABA-mimetics such as 3-aminopropanesulphonic acid (3-APS) or isoguvacine. We propose to designate the classical site as the GABA A and the novel site as the GABA B receptor. The beta-p-chlorophenyl derivative of GABA, baclofen, is stereospecifically active at the GABA B site whereas it is devoid of activity at the classical GABA A3 site. We now report that high-affinity saturable binding of 3H-baclofen and 3H-GABA to the GABA B site can be detected in fragments of crude synaptic membranes prepared from rat brain. The results support the concept of a novel GABA receptor within the mammalian brain and show that GABA and baclofen can compete for the same recognition site.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259535     DOI: 10.1038/290149a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  183 in total

1.  Possible involvement of GABA(A) and GABA(B) receptors in the inhibitory action of lindane on transmitter release from cerebellar granule neurons.

Authors:  I Damgaard; G Nyitrai; I Kovács; J Kardos; A Schousboe
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

2.  The effects of baclofen on calcium channel currents in dorsal sensory cells of the spinal cord in the lamprey.

Authors:  I V Batueva; J T Buchanan; E A Tsvetkov; A K Sagatelyan; N P Veselkin
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

Review 3.  Neurochemical and molecular pharmacological aspects of the GABA(B) receptor.

Authors:  K Kuriyama; M Hirouchi; H Kimura
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

4.  The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx.

Authors:  J H White; R A McIllhinney; A Wise; F Ciruela; W Y Chan; P C Emson; A Billinton; F H Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen.

Authors:  M D Wood; K L Murkitt; S Q Rice; T Testa; P K Punia; M Stammers; O Jenkins; N A Elshourbagy; U Shabon; S J Taylor; T L Gager; J Minton; W D Hirst; G W Price; M Pangalos
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.

Authors:  K Akahane; M Sekiguchi; T Une; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

7.  Effects of the putative antagonists phaclofen and delta-aminovaleric acid on GABAB receptor biochemistry.

Authors:  T N Robinson; A J Cross; A R Green; J M Toczek; B R Boar
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

8.  Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat.

Authors:  Jonathan Brouillette; Réjean Couture
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  Studies of GABA(B) receptors labelled with [(3)H]-CGP62349 in hippocampus resected from patients with temporal lobe epilepsy.

Authors:  A P Princivalle; J S Duncan; M Thom; N G Bowery
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

10.  Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine.

Authors:  Neetu Tyagi; David Lominadze; William Gillespie; Karni S Moshal; Utpal Sen; Dorothea S Rosenberger; Mesia Steed; Suresh C Tyagi
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.